ZK Drugresist - Automatic Extraction of Drug Resistance Mutations and Expression Level Changes from Medline Abstracts

  title={ZK Drugresist - Automatic Extraction of Drug Resistance Mutations and Expression Level Changes from Medline Abstracts},
  author={Zoya Khalid and Ugur Sezerman},
Drugs are small molecules that generally work by binding to its target which is often a protein. This ligand molecule binding helps in the treatment of various diseases. Major obstacle to treat complex diseases is the phenomena underlying drug resistance mechanisms which are not fully understood so far. Previously reported literature has mentioned few of the motives behind this complex mechanism which dominantly include protein missense mutations and the changes in the expression… 
1 Citations

Figures and Tables from this paper



Extracting causal relations on HIV drug resistance from literature

A novel method to extract and combine relationships between HIV drugs and mutations in viral genomes based on natural language processing (NLP) which produces grammatical relations and applies a set of rules to these relations is presented.

Application of Automatic Mutation-gene Pair Extraction to Diseases

An automated system that automatically extracts mutation-gene pairs from Medline abstracts for a disease query and overcomes the problems of information retrieval from public resources and reduces the time required to access relevant information, while preserving the accuracy of retrieved information is described.

EnzyMiner: automatic identification of protein level mutations and their impact on target enzymes from PubMed abstracts

An automated system which automatically identifies the PubMed abstracts that contain an amino-acid-level mutation and then classifies them according to the mutation's effect on the enzyme, as well as checking whether the abstract is related to a disease with the help of information extraction and machine learning techniques is presented.

CancerDR: Cancer Drug Resistance Database

A database “CancerDR”, which provides information of 148 anti-cancer drugs, and their pharmacological profiling across 952 cancer cell lines, will be very useful for identification of genetic alterations in genes encoding drug targets, and in turn the residues responsible for drug resistance.

EDGAR: extraction of drugs, genes and relations from the biomedical literature.

The mechanisms for automatically generating assertions about drugs and genes relevant to cancer and on a simple application, conceptual clustering of documents are reported on.

Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen.

A large set of 934 high-confidence P-glycoprotein substrates or nonsubstrates was created by enforcing agreement with an orthogonal criterion involving P-gp overexpressing ADR-RES cells, validating the method's predictive ability.

CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer

This study is the first reporting an association between CHEK2 mutations and therapy resistance in human cancers and to document mutations in two genes acting direct up/down-stream to each other to cause therapy failure, emphasizing the need to investigate functional cascades in future studies.

Mechanisms of cancer drug resistance.

The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer

Detecting Gene Symbols and Names in Biological Texts: A First Step toward Pertinent Information Extraction.

A program for the identification of gene symbols and names inside sentences has been devised, made up of a series of sieves of different natures, lexical, morphological and semantic, to distinguish among the words of a sentence those which can only be potential gene symbols or names.

Molecular mechanisms of drug resistance

The signalling pathways involved in regulating tumour cell response to chemotherapy more completely than ever before are characterized, which will facilitate the future development of rational combined chemotherapy regimens, in which the newer targeted therapies are used in combination with cytotoxic drugs to enhance chemotherapy activity.